Clinical Trial Update: Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating nivolumab with or without bevacizumab or ipilimumab before surgery in patients with resectable metastatic renal cell carcinoma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING